$ICE

Bowen Sharon sold $101K of ICE

Bowen Sharon sold 667 shares of Intercontinental Exchange, Inc. (ICE) at $151.28 ($0.10M total) on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bowen Sharon
Published May 27, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ICE
Neutral
high confidence
Mentioned
$ICE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICENeutralLow
01

Why it matters

Because the sale is explicitly under a pre-arranged Rule 10b5-1 plan, it is generally treated as routine liquidity rather than a strong signal about near-term fundamentals.

02

Market read

A disclosed 10b5-1 insider sale for roughly $100.9K is unlikely to drive a sustained price move by itself.

03

What to watch

The article provides no context on whether other directors/officers are selling or buying, nor any linkage to earnings windows or guidance changes.

Relevance 6/10Timing: Disclosure filed 2026-05-27; any micro-reaction would be most likely on/around filing time.

Background

The article is a SEC Form 4 insider transaction disclosure for Intercontinental Exchange, Inc. (ICE).

Company-level read

Ticker impact

$ICENeutralHigh confidence
Context

Intercontinental Exchange director Bowen Sharon sold 667 shares in an open-market transaction for about $100.9K under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted given the pre-arranged 10b5-1 plan.

Evidence & confidence

The filing specifies an open-market sale executed under a pre-arranged Rule 10b5-1 plan, which typically lowers the probability of an information-driven move.

Market effects

Minimal; single-director 10b5-1 sale does not reset sector expectations for exchanges/market infrastructure.

None indicated; ICE is US-listed and the event is company-specific insider disclosure.

None indicated; no cross-border deal, regulation, or operational change mentioned.

Counterpoint

Even with 10b5-1, repeated insider sales can coincide with portfolio rebalancing; traders may still watch for clustering of similar filings.

Key entities

  • Intercontinental Exchange, Inc.

    Subject of the Form 4 insider transaction; director Bowen Sharon sold 667 shares.

  • Bowen Sharon

    Director who executed an open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$ICEMedAI 8/10

ICE agrees $5.7 billion MarketAxess acquisition, BlackRock expands tokenised fund access in Europe

Intercontinental Exchange agreed to acquire MarketAxess for $5.7 billion, expanding ICE’s role in electronic fixed-income trading, data and analytics. BlackRock launched 12 tokenised share classes for European money-market funds with $311 billion AUM using JPMorgan’s Kinexys. Other items include India’s NSE closing auction for derivative-linked stocks and Boerse Stuttgart Digital’s Tradias merger.

$BLKMed

Circle names BlackRock, Visa and others as initial Arc partners, signaling early institutional backing

Circle named initial Arc network partners, including BlackRock, ICE, Visa, Mastercard, DTCC, Galaxy, Global Payments, MoneyGram, SBI, Standard Chartered and Sumitomo. Arc launches publicly Sept. 16 with 10-12 operators initially. Circle, which issues USDC, plans validator and staking governance and integrations for tokenized settlement. Circle reports quarterly earnings Wednesday.

$ICEHighAI 9/10

ICE Will Pay $6 Billion to Buy MarketAxess and Take On Bond Trading

Intercontinental Exchange (ICE) will acquire MarketAxess Holdings for $167 per share in cash, valuing the deal at about $5.7 billion (roughly $6 billion). The offer is a 33% premium to the prior close. ICE expects about $100 million in annual cost savings within three years. Closing is targeted for H1 2027, pending shareholder and regulatory approvals.

$ICEMedAI 8/10

Intercontinental Exchange, Inc. Q2 2026 Earnings Call Summary

Intercontinental Exchange (ICE) summarized Q2 2026 results, citing 8% growth in recurring revenue despite lower episodic volatility. ICE expects MarketAxess acquisition to close H1 2027, targeting $100M annualized expense synergies by year three. It raised 2026 capex to about $850M, recurring revenue growth guidance to 7% to 8%, and authorized a $4B buyback.